C3/Ig and Ig/C3 two-component-determined circulating immune complexes (TCIC) in patients with HCV infection

FEMS Immunology and Medical Microbiology

Volumn 36, Issue 1-2, 2003, Pages 77-82

  Wang, Sanying ^a   Yang, Tianci ^a   Zhang, Jianying ^a,b   Xiao, Shengxian ^c   Peng, Xuanxian ^a  

^a XIAMEN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Hepatitis C; Hepatitis C virus; Two component determined circulating immune complexes

Indexed keywords

ALANINE AMINOTRANSFERASE; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

EID: 0242500474     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00062-2     Document Type: Article

References (26)

1. Haydon G.H., Jarvis L.M., Simmonds P., Harrison D.J., Garden O.J., Hayes P.C. Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population. Gut. 40:1997;128-132.
2. Tsai J.F., Jeng J.E., Chang W.Y., Ho M.Sh., Lin Z.Y., Tsai J.H. Circulating immune complexes in chronic hepatitis C. J. Med. Virol. 46:1995;12-17.
3. Tsai S.L., Liaw Y.F., Chen M.H., Huang C.Y., Kuo G. Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity. Hepatology. 25:1997;449-458.
4. Kuzushita N., Hayashi N., Katayama K., Kanto T., Oshita M., Hagiwara H., Kasahara A., Fusamoto H., Kamada T. High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C. Gastroenterology. 32:1997;169-174.
5. Monsnier J.F., Degott C., Marcellin P., Henin D., Erlinger S., Benhan J.P. The intraportal lymphoid nodule and its environment chronic active hepatitis C: An immunohistochemical study. Hepatology. 17:1993;366-371.
6. Kobayashi M., Tanaka E., Matsumoto A., Ichijo T., Kiyosawa K. Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C. J. Gastroenterol. Hepatol. 12:1997;73-76.
7. Nouri Aria K.T., Sallie R., Sanger D., Alexander G.J., Smith H., Byrn Portmann B., Eddleston A.L., Williams R. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by situ hybridization. J. Clin. Invest. 91:1993;2226-2234.
8. Peng X.X., Zhu H., Zhang J.Y., Wang S.Y. Analysis of HCV-Ig isotype complexes by a novel immuno-capture RT-PCR methods. Scand. J. Immunol. 54:2001;409-413.
9. Peng X.X., Wang S.Y., Zhang J.Y., Zhu H. Analysis of HCV-immunoglobulin isotype complexes provide new insights into antibody response to HCV. Scand. J. Immunol. 56:2002;94-100.
10. Peng X.X., Tao Y.Zh., Wainberg M.A., Brenner B.G. Immunoglobulin and complement complexes in blood following infection with human immunodeficiency virus type 1. Clin. Diagn. Lab. Immunol. 3:1996;128-132.
11. Kion T.A., Hoffmann. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science. 253:1991;1138-1140.
12. De Quiros J.F., Pinto V., Hevia S., Vigon R. Immune complex-mediated haemolytic anaemia and Evans syndrome induced by diclofenac. Vox Sang. 72:1997;121-123.
13. Tarasova N.S., Beloborodova E.I. Immunological aspects of circulating immune complexes in kidney diseases in patients with chronic alcoholism. Ter. Arkh. 70:1998;61-63.
14. Ramanathan V.D., Thyagi P., Ramanathan U., Katoch K., Ramu G. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions. Indian J. Lepr. 70:1998;153-160.
15. Margarite J.M. Levels of IgM and IgA circulating immune complexes in dogs with leishmaniasis. Z.bl. Vet.med. 45:1998;263-267.
16. Gupta I., Jain A., Singh N.B., Chaturvedi V., Agarwal S.K. Role of antigen specific circulating immune complexes in diagnosis of tuberculosis. Int. J. Tuberc. Lung Dis. 2:1998;456-461.
17. Anyaegbu C.C., Okpala I.E., Aken'ova A.Y., Salimonu L.S. Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia. APMIS. 107:1999;699-702.
18. Zhu H., Wang S.Y., Zhang J.Y., Peng X.X. Analysis of complement-bound HCV complexes using a novel immuno-capture RT-PCR method. Scand. J. Immunol. 56:2002;538-542.
19. Digeon M., Laver M., Riza J., Bach J.F. Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. J. Immunol. Methods. 16:1977;165-178.
20. Arh-Tuan N., Novàk E. Detection and quantitation of hepatitis B surface antigen imune complexes (HBsAg-CICs) by an antigen-specific method. Detection and quantitation of in vivo prepared HBsAg-ICs. J. Immunol. Methods. 33:1980;293-301.
21. Peng X.X. Progress on two-component-determined circulating immune complexes. Shanghai J. Immunol. 16:1996;315-317.
22. Peng X.X., Wang S.Y., Huang X.F. Significance of Ig (IgM and IgG) and C3 component-determined circulating immune complexes in HBV infected patients. Chin. J. Virol. 13:1997;228-233.
23. Musset L., Ghillani P., Lunel F., Cacoub P., Cresta P., Frangeul L., Rosenheim M., Preud'homme J. Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-α therapy. Immunol. Lett. 55:1997;41-45.
24. Cicardi M., Cesana B., Del Ninno E., Pappalardo E., Silini E., Agostoni A., Colombo M. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J. Viral. Hepatitis. 7:2000;138-143.
25. Dumestre-Perard C., Ponard D., Drouet C., Leroy V., Zarski J.P., Dutertre N., Colomb M.G. Complement C4 monitoring in the follow-up of chronic hepatitis C treatment. Clin. Exp. Immunol. 127:2002;131-136.
26. Lamprecht P., Moosig F., Gause A., Herlyn K., Csernok E., Hansen H., Gross W.L. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis. Ann. Rheum. Dis. 60:2001;385-390.